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NevirapineAbstract Interactions in proteins have been studied using several chemical information techniques
including quantum chemical methods that are applied to truncated systems composed of the ligand
molecule and the surrounding amino acids of the receptor. In this work we adopt an approach to
study these interactions accounting for as many as possible explicit solvent molecules and without
the need of a fragmented calculation. Furthermore, we embed our quantum chemical calculations
within a molecular dynamics framework that enables a fundamentally fast system for quantum
molecular dynamic simulations (QCMD). Central to this new system for QCMD is the tight binding
QC system, newly developed in our laboratories, and which combined with the MD paradigm
results in an ultra accelerated QCMD method for protein–ligand interaction evaluations. We have
applied our newly developed method to the Nevirapine (NVP)–Reverse Transcriptase (RT) system.
We show how the proposed method leads us to new ﬁndings. The advanced QCMD was applied to
a system of RT with NVP and it has led to the knowledge of speciﬁc groups and atoms that interact
with surrounding amino acids of RT and help in drug binding. The information derived from this
calculation may be used in designing drugs for NVP resistant virus strains that have binding capa-
bility like NVP.
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
HIV-1 Reverse Transcriptase (HIV-1 RT) is an important and
extensively studied antiviral target for the chemotherapy of
AIDS because of its key role in virus replication. The inhibitorsof HIV-1 RT can be divided into two main classes, nucleoside
RT inhibitors (NRTIs) and non-nucleoside RT inhibitors
(NNRTIs) (Rizzo et al., 2001; Mitsuya et al., 1990; Katz and
Skala, 1994; Wang et al., 2001). The NNRTIs analogs such as
Nevirapine, TIBO, HEPT, and Efavirenz are non-competitive
inhibitors that lock the polymerase active site in an inactive con-
formation (Archer et al., 2001; De Clercq, 1996; Jonckheere
et al., 2000). AlthoughNNRTIs are highly speciﬁc and less toxic
than nucleoside inhibitors, their therapeutic effectiveness is lim-
ited by relatively rapid emergence of drug-resistant HIV-1
strains. NNRTIs include structurally unrelated subclasses of
compounds that bind to a common allosteric site, adjacent to
Figure 1 Nevirapine (shown as space ﬁll model) and protein part falling under 10 A˚ radii from Nevirapine with water molecules.
Table 1 Comparison of orbital population of Nevirapine and
Tyrosine 188 system from DFT calculation and colors.
Castep Colors
%s %p %s %p
Hydrogen 100 0 100 0
Carbon 28.36 71.64 30.06 69.94
Nitrogen 27.21 72.79 24.93 75.07
Oxygen 26.98 73.02 23.21 76.79
720 K.K. Sahu et al.the NRTI binding site, by a similar three-dimensional arrange-
ment (Archer et al., 2001; De Clercq, 1994; Hannongbua et al.,
2001). Nevirapine, a ﬁrst generation NNRTI, has been
approved for clinical use for the therapy of AIDS. Mutations
of amino acid residues in the binding pocket of RT reduce sen-
sitivity signiﬁcantly, and, therefore, new potent drugs have been
widely developed.
However, despite intensive experimental investigations, the
detailed origin of enzyme–inhibitor interaction, a question of
crucial importance, remains to be unclear. A better under-
standing is vital for the analysis of activities of mutant or
designed proteins, and for the design of inhibitors as pharma-
ceutical lead compounds. Therefore, theoretical investigation
has been an alternative method for studies of the enzyme–
inhibitor interaction in detail. However, such investigation
of larger molecular system is limited by the computational
effort required and the accuracy of the method used.
Recently, accurate molecular modeling for larger molecules,
such as those in molecular biology, became more feasible
due to new developments in computational chemistry
(Maseras and Morokuma, 1995; Humbel et al., 1996;
Svensson et al., 1996).
HIV-1 Reverse Transcriptase (RT) is an important target
for drugs used in the treatment of AIDS. Drugs known as
non-nucleoside RT inhibitors (NNRTI) appear to alter the
structural and dynamical properties of RT, which in turn inhi-
bit RT’s ability to transcribe. Molecular dynamics (MD), prin-
cipal component analysis (PCA), and binding free energy
simulations are employed to explore the dynamics of RT and
its interaction with the bound NNRTI Nevirapine, for both
wild-type and mutant (V106A, Y181C, Y188C) RT. These
three mutations commonly arise in the presence of Nevirapine
and result in resistance to the drug. The mutations cause a loss
of van der Waals interactions between the drug and the bind-
ing pocket. This suggests that a good inhibitor should efﬁ-
ciently enter and maximally occupy the binding pocket,thereby interacting effectively with the amino acids around
the binding pocket (Zhou et al., 2005).2. Method
2.1. Periodic density functional theory method
Periodic DFT calculations were performed by using the
DMol3 software (DMol3, version4.0, Accelrys, 1999). In order
to reduce the computational cost, all core electrons were repre-
sented by effective core pseudopotentials. In this study, double
numerical sets with polarization base were employed. Vosk–
Wilk–Nusair (VWN) (Vosko et al., 1980) local correlation
functional was used to optimize geometries. Generalized gradi-
ent approximation (GGA) in terms of Perdew–Wang exchange
and correlation functional (Perdew et al., 1992) was used to
evaluate energies. The orbital population and bond popula-
tions were obtained using truncated models by the DFT
method that employs Cambridge serial total energy package
(CASTEP). In CASTEP calculations, we used GGA in terms
of Perdew–Burke–Ernzerhof functional (PBE) (Perdew et al.,
1996). The crystal lattice size used for DFT calculations
on truncated Nevirapine-Tyr188 acid complex was
20 A˚ · 20 A˚ · 20 A˚.
NVP Tyrosine residue
Figure 2 Truncated model of NVP–Tyrosine complex on which colors and castep calculations were done for comparison of orbital
population.
Table 2 Bond population, bond energy and distance between
Nitrogen atom from the pyridine ring of Nevirapine and
hydrogen from Tyrosine 188 residue from RT enzyme.
Bond Distance (A˚) Energy (kcal/mol) BP
N1–H1 2.96 4.6 0.02
Table 3 Bond population, bond energy and distance between
hydrogen atom from the cyclopropane ring of Nevirapine and
Nitrogen from Tyrosine 181 residue from RT enzyme.
Bond Distance (A˚) Energy (kcal/mol) BP
N2–H2 2.99 6.8 0.042
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method
2.2.1. Ultra-accelerated quantum chemical molecular dynamics
(UA-QCMD) simulator
Our novel UA-QCMD simulator consists of two parts. The
ﬁrst part is the tight-binding QCMD (TB-QCMD) simulator.
In this simulator, an electronic structure calculation is per-
formed by solving the Schro¨dinger equation (HC= eSC; H,
C, e, and S refer to the Hamiltonian matrix, eigenvectors,
eigenvalues, and overlap integral matrix, respectively) with
the diagonalization condition (CTSC= I; I refers to the unit
matrix). In order to determine the off-diagonal elements ofN1
NVP
Figure 3 Interaction between Nitrogen atom from the pyridine ring
enzyme.H, and Hrs, the corrected distance-dependent Wolfsberg-
Helmholtz formula (Calzaferri et al., 1989) (Eq. (1)) was used.
Hrs ¼ K
2
SrsðHrr þHssÞ ð1Þ
In order to solve the Schro¨dinger equation in this simula-
tor, parameters for Hamiltonian matrix H are used, which will
be explained later. For electronic structure calculations using
our TB-QCMD simulator, the total energy of a system is
obtained by using the following equation,
E ¼
Xocc
k¼1
nkek þ
XN
i¼1
XN
j¼iþ1
ZiZje
2
rij
þ
XN
i¼1
XN
j¼iþ1
Erepulij ðrijÞ; ð2ÞH1 Tyr188 
of Nevirapine and hydrogen from Tyrosine 188 residue from RT
H2
N2
Nevirapine
Tyrosine181
Figure 4 Interaction between hydrogen atom from the cyclopropane ring of Nevirapine and Nitrogen from Tyrosine 181 residue from
RT enzyme.
Table 4 Bond population, bond energy and distance between
Oxygen (O3) from Nevirapine and Hydrogen (H3) from
Valine106.
Bond Distance (A˚) Energy (kcal/mol) BP
H3–O3 2.9 4.9 0.02
722 K.K. Sahu et al.where the ﬁrst, second, and third terms on the right-hand side
refer to the molecular orbital (MO) energy, columbic energy,
and exchange-repulsion energy, respectively. The ﬁrst term
on the right-hand side of Eq. (2) is rewritten as follows,
Xocc
k¼1
nkek ¼
Xocc
k¼1
X
r
nkðCkrÞ2Hrr þ
Xocc
k¼1
X
r
X
s
nkCkrCksHrs; ð3Þ
where the ﬁrst and second term on the right-hand side refer to
the mono-atomic contribution to the binding energy and the
diatomic contribution to the binding energy, respectively (nk
is the number of electrons occupied in kth molecular orbital).
A binding energy calculated from the second term of Eq. (3) is
used for the determination of the DAB parameter in the
Morse-type 2-body interatomic potential function described
as Eq. (4),
EAB ¼ DABfexp 2bABðRAB  RABÞ
  2
 exp bABðRAB  RABÞ
 g ð4Þ
where EAB, DAB, bAB, RAB, and R
*
AB refer to the interatomic
potential energy between atoms A and B, binding energy
between atoms A and B, factor for potential curve, interatomic
distance between atoms A and B, and equilibrium interatomic
distance between atoms A and B, respectively. The second part
of our UA-QCMD simulator is the classical MD simulator. In
our MD simulator, a Verlet algorithm is employed to integrate
equation of motion.
Quantum chemical calculations were carried out using Col-
ors program, which is based on our original tight-binding
approximation (Kubo et al., 2004; Elanany et al., 2003; Luo
et al., 2003; Jung et al., 2003). In the ‘‘Colors’’ program, high
efﬁciency of computation is realized by adopting parameters in
the Hamiltonian. In our program, the parameters are deter-
mined on the basis of DFT calculation results. This can realizeboth high calculation speed and high accuracy (Elanany et al.,
2002, 2003; Sasata et al., 2003; Jung et al., 2003). The crystal
lattice size used for ‘Colors’ calculations on truncated Nevira-
pine-Tyr188 complex was 20 A˚ · 20 A˚ · 20 A˚.
We used a combination of MD simulation with the quan-
tum chemical method that allows the computation of elec-
tronic properties of the system with conventional MD to
simulate the dynamic behavior of the system when local prop-
erties such as charges and the free ﬁeld vary. The combination
of MD with QC enables the identiﬁcation of the interacting
ligand atoms and groups of the enzyme and characterization
of the main terms leading to the interaction. The simulation
was carried out by Ryudo program for 150,000 steps with an
integration time of 0.1 fs. Prior to this simulation, the trun-
cated system was subjected to a single point quantum chemical
calculation by Colors program. The Morse potential between
different pairs of atoms was used for MD simulation by
New-Ryudo program. This combination of Colors and New-
Ryudo was repeated for three times to get the stability and
accuracy of results.
3. Results and discussion
We carried out quantum chemistry-based molecular dynamics
simulation using ‘‘Colors’’ and ‘‘New-Ryudo’’ program to
Val106
OH
H2N
O
H
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H3
O3
Carbon 
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H3
N
N
NH
O
N
O3
NVP
Figure 5 Interactions between Oxygen from Nevirapine and Hydrogen from Valine106.
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Reverse Transcriptase enzyme.
Fig. 1 shows Nevirapine (shown as space ﬁll model) and
protein part falling under 10 A˚ radii from Nevirapine with
water molecules. This model was used for our MD simulation.
This model contains 11,520 atoms, which includes 2699 water
molecules. The water molecules were added in a volume of
50 A˚ · 50 A˚ · 50 A˚. This system was simulated for 15 ps.
Table 1 shows the comparison of orbital population of
NVP-TYR truncated system (Fig. 2) from DFT and colors
calculation.
We found that there is a good agreement between %s and
%p-orbital populations obtained with DFT and colors calcu-
lations. The bond population, bond energy and the distance
shown in Table 2 indicate that there is hydrogen-bonding
interaction between Nitrogen atom (N1) from the pyridine ring
of Nevirapine and hydrogen (H1) from Tyrosine 188 residue
from RT enzyme (as shown in Fig. 3). The bond population,
bond energy and the distance shown in Table 3 indicate that
there is hydrogen-bonding interaction between hydrogen atom
(H2) from the cyclopropane ring of Nevirapine and Nitrogen
(N2) from Tyrosine 181 residue from RT enzyme (as shown
in Fig. 4). The bond population, bond energy and the distance
shown in Table 4 indicate that there is hydrogen-bonding
Interaction between Oxygen (O3) from Nevirapine and Hydro-
gen (H3) from Valine106 (as shown in Fig. 5).
4. Conclusion
Interactions in protein have been studied using several chemi-
cal information techniques including quantum chemical meth-
ods that are applied to truncated systems composed of the
ligand molecule and the surrounding amino acids of the recep-
tor. In this work, we embed our quantum chemical calcula-
tions within a molecular dynamics framework that enables a
fundamentally fast system for quantum molecular dynamic
simulations.In the present work we propose the use of ultra accelerated
quantum chemical molecular dynamics (QCMD) to study the
interactions between RT enzyme and anti-HIV drug molecule
for the ﬁrst time. Central to our methodology is the system for
QC based on the tight binding methodology, encoded in the
COLORS system developed in our laboratories. The proposed
methodology enables treatment of a large molecular system
including explicit solvent molecules, an elusive aspect to more
orthodox quantum chemical calculations based on ﬁrst princi-
ple calculations. The ultra accelerated QCMD was applied to a
system of RT with Nevirapine, and it has led to new insights,
not unveiled so far, of the atoms and groups of NVP drug and
RT enzyme involved in hydrogen bonding interactions in the
binding pocket of the enzyme.
We conﬁrmed that tight binding quantum chemical molec-
ular dynamics simulation program developed in our labora-
tory is an effective tool to investigate bio-molecular systems
as demonstrated by this study on RT enzyme. Using our in-
house programs, we found those atoms and groups that are
actively involved in the interactions between NVP and RT.
This information is useful in designing potent analogs of
Nevirapine, which may act as substitute for NVP in case of
NVP-resistant strains of Human Immunodeﬁciency Virus.Acknowledgement
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